
Subacute Schlerosing Panencephalitis
Abstract
A 10-year old Nicaraguan boy with SSPE was treated with intraventricular biosynthetic alpha 2b interferon (Schering, Intron A) 1 million units twice weekly for 5h months, at the Children’s Hospital of Los Angeles, Neurology Division, Los Angeles, CA.
DOI: https://doi.org/10.15844/pedneurbriefs-1-7-12 | Journal eISSN: 2166-6482
Language: English
Page range: 54 - 54
Published on: Dec 1, 1987
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
© 1987 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.